Service Tax Additional
select a format
Recent Viewed Reports
Why Ken Reasearch?
While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"
We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"
The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"
Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"
We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"
Inferior Vena Cava Filters-Current and Future Players
Venous thromboembolism (VTE) is a potentially lethal disease consisting of two related conditions: deep vein thrombosis (DVT) and pulmonary embolism (PE). There remains a small subset of patients with absolute or relative contraindication to anticoagulation, at high risk of embolism, or prone to PE despite adequate anticoagulation. For these patients, physicians may opt to place an inferior vena cava filter (IVCF) as a therapeutic or prophylactic treatment. While historically the adoption of IVCF increased rapidly due to the introduction of retrievable devices, new clinical evidence has come to light that is likely to inhibit any significant market expansion over the coming years.
The report provides up-to-date information and in-depth analysis on the key players that shape this market. This includes an analysis of company market shares, industry trends, and corporate strategy. The report identifies the unmet needs in the market while providing an understanding of physicians' perceptions and decision-making processes in using and evaluating the adoption of different types of devices.
*This is an on-demand report and will be delivered within 4 working days (excluding weekends) of the purchase.
"What Physicians Think" quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. In this report you will understand the perceptions of leading vascular surgeons and interventional radiologists from around the world. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.
Investigation of current and future market competition in the IVCF market.
Competitive Assessment including device approval analysis.
Coverage of key market players and company profiles including business description, financial overview, product portfolio assessment, and SWOT analysis.
Strategic Assessment of the market through market impact analysis, future market scenario, and company analysis.
Reasons To Buy
Gain a high level view of the trends shaping and driving the IVCF market.
Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
Drive revenues, formulate effective sales and marketing strategies, and gain in-depth understanding of the competitive landscape.
Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products.
Create an effective counter-strategy to gain a competitive advantage against those currently in the market.
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2.1 Related Reports
3 Competitive Assessment
3.1 Market Share Analysis
3.2 Key Companies & Product Profiles
3.2.2 Argon Medical Devices
3.2.3 B. Braun
3.2.4 Boston Scientific
3.2.5 C.R. Bard
3.2.6 Cook Medical
3.2.9 Other Players
3.3 Pipeline Products Assessment
3.4 Clinical Trials to Watch
4.3.3 Secondary Research
4.4 Forecasting Methodology
4.5 Primary Research Summary
4.6 About the Authors
4.6.1 Premdharan Meyyan, Cardiovascular Analyst, Medical Devices
4.6.2 Linda Tian, Msc, Managing Analyst, Medical Devices
4.6.3 David Brady, Director of Operations-Market Research
4.6.4 Tyler Fletcher, Global Head of Medical Devices
4.7 About GlobalData
1.2 List of Figures
Figure 1: Global Market Shares for Inferior Vena Cava Filters, by Company, 2015
Figure 2: Vascular Surgeons Survey Primary Research Participants, by Country
1.1 List of Tables
Table 1: ALN-Company SWOT Analysis
Table 2: ALN-Marketed Products Assessment
Table 3: Argon Medical Devices-Company SWOT Analysis
Table 4: Argon Medical Devices-Marketed Products Assessment
Table 5: B. Braun-Company SWOT Analysis
Table 6: B. Braun-Marketed Products Assessment
Table 7: Boston Scientific-Company SWOT Analysis
Table 8: Boston Scientific-Marketed Products Assessment
Table 9: C.R. Bard-Company SWOT Analysis
Table 10: C.R. Bard-Marketed Products Assessment
Table 11: Cook Medical-Company SWOT Analysis
Table 12: Cook Medical-Marketed Products Assessment
Table 13: Cordis (Cardinal Health)-Company SWOT Analysis
Table 14: Cordis-Marketed Products Assessment
Table 15: Volcano-Company SWOT Analysis
Table 16: Volcano-Marketed Products Assessment
Table 17: Other Players Assessment
Table 18: Pipeline Products Assessment
Table 19: Clinical Trials to Watch
Single User License:
Corporate User License:
Argon Medical Devices